- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01295359
Impact of a Hospital Physical Therapy Program on Chronic Obstructive Pulmonary Disease (COPD) Patients
March 18, 2011 updated by: Universidade Federal de Sao Carlos
Impact of a Hospital Physical Therapy Program on Exacerbated Chronic Obstructive Pulmonary Disease Patients: A Randomized Controlled Trial
The Chronic Obstructive Pulmonary Disease is a leading global cause of morbidity and mortality, so it's important to find actions that could improve quality of life and decrease the mortality.
The objective of this study is to verify if a ground walking program applied to hospitalized exacerbated COPD patients has effects in quality of life, exercise capacity, airways obstruction, body composition, heart rate variability, quadriceps isometric force and in the "Body-mass index, Airway Obstruction, Dyspnea, Exercise Capacity index" (BODE index).
An evaluators-blinded randomized controlled study will be conducted in "Hospital Escola Municipal de São Carlos" where forty patients will be recruited to participate.
The volunteers will be randomized in two groups with twenty patients, the usual care group, that will receive only the usual care of the hospital; and the trained group that will receive the same care, but will also participate in a ground walking program associated with respiratory exercises.
It will be evaluated, in the start and at the end of the program, the health related and general quality of life and the Barthel index.
Daily, the patient will be submitted to the Six Minute Walk Test, to a body composition analysis, to a hand grip test and to a dyspnea assessment, and will be calculated its BODE index.
All patients will be invited to a follow up in the 12th and 24th weeks after hospital discharge, when they would receive the same evaluation of the last day in the hospital.
All the collected data will be expressed in means and standard deviations or medians and range when appropriated.
It will be chosen appropriated tests to compare and correlate them.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
São Paulo
-
São Carlos, São Paulo, Brazil, 13566-488
- Recruiting
- Hospital Escola Municipal "Dr Horácio Carlos Panepucci
-
Contact:
- Mariza Borges Brito de Souza, PhD
- Phone Number: 33625555
- Email: souzamar@ufscar.br
-
Principal Investigator:
- Juliano Ferreira Arcuri, Especialist
-
Principal Investigator:
- Adriana Sanches Garcia de Araujo, Masters
-
Principal Investigator:
- Valéria Amorim Pires Di Lorenzo, PhD
-
Sub-Investigator:
- Bruna Varanda Pessoa, Masters
-
Sub-Investigator:
- Julia Gianjoppe dos Santos, Especialist
-
Sub-Investigator:
- Audrey Borghi-Silva, PhD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
50 years to 85 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- COPD Patients (FEV1/FVC < 0,70; FEV1 > 30% and < 80%)
- Hospitalized for exacerbation of COPD
Exclusion Criteria:
Conditions that could restrict walking
- Skeletal-muscle and joint disturbs
- Extreme Obesity (BMI > 35kg/m²)
- Heart Failure (New York Heart Association class III and IV)
- Uncontrolled infection (fever > 38ºC and leukocytosis > 10000 cels/dl)
- Need of Invasive Mechanical Ventilation after the beginning of the program
Previous Diagnosis of:
- Stroke
- Epilepsy
- Coagulation disorders (INR > 1,5 or platelets < 50.000/m³)
- Psychiatric Disorders or severe agitation
- Cardiac or respiratory instability
- Oxygen therapy > 3L/min at rest
- Respiratory Rate > 30 breaths/min at rest
- Tachycardia and Bradycardia
- Vasoactive Drugs need
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Trained Group
This group will receive the usual care of the hospital and a ground walking training program associated with respiratory exercises.
|
The patients will walk on a corridor, for 40min, once a day.
The speed will be controlled through a metronome, that will be programed to a frequency of steps/min determinated as 80% of the mean frequency of steps performed in six minutes walk test of that day.
The 40min will be divided in 3min of walk and 2min of rest, totalizing 24min of exercise and 16min of rest.
Furthermore, these patients, in sitting position, will receive orientation to do calm and slow inspirations and expirations, associated with pursed lips expiration.
They will try to maintain its Respiratory Rate in 6bpm, during four minutes.
Other Names:
|
|
No Intervention: Usual Care Group
This group will only receive the usual care of the hospital, including physical therapy
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Exercise Capacity
Time Frame: Daily, as soon as medically appropriated, during the hospitalization
|
It will be evaluated through the six minutes walking distance, performed according to ATS rules.
|
Daily, as soon as medically appropriated, during the hospitalization
|
|
Change in BODE index
Time Frame: Daily, as soon as medically appropriated, during the hospitalization
|
The Body-Mass Index, Airways Obstruction, Dyspnea, Exercise Capacity (BODE) index.
This is a multidimensional evaluation that includes Forced Expiratory Volume in the first second, Body-Mass Index, 6 Minutes Walking Distance and mMRC score.
It is an index to predict mortality.
|
Daily, as soon as medically appropriated, during the hospitalization
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Perceived Dyspnea
Time Frame: Daily, as soon as medically appropriated, during the hospitalization
|
Dyspnea during the six minutes walk test through the BORG CR10 scale
|
Daily, as soon as medically appropriated, during the hospitalization
|
|
Change in Perceived discomfort in lower limbs
Time Frame: Daily, as soon as medically appropriated, during the hospitalization
|
Evaluated during the six minutes walk test through the BORG CR10 scale
|
Daily, as soon as medically appropriated, during the hospitalization
|
|
Change in Variation in Heart Rate
Time Frame: Daily, as soon as medically appropriated, during the hospitalization
|
It will be evaluated the variation in the Heart Rate during the six minutes walk test (Exercise Peak - rest)
|
Daily, as soon as medically appropriated, during the hospitalization
|
|
Change in the need of oxygen therapy
Time Frame: Daily, as soon as medically appropriated, during the hospitalization
|
Will be evaluated the need of oxygen therapy during the six minutes walk test
|
Daily, as soon as medically appropriated, during the hospitalization
|
|
Change in Handgrip Isometric Force
Time Frame: Daily, as soon as medically appropriated, during the hospitalization
|
It will be evaluated through a hand grip dynamometer.
|
Daily, as soon as medically appropriated, during the hospitalization
|
|
Change in General Quality of Life
Time Frame: first day of the protocol and at the day of discharge
|
It will be evaluated through the SF-36 questionnaire
|
first day of the protocol and at the day of discharge
|
|
Change in Body Composition
Time Frame: Daily, as soon as medically appropriated, during the hospitalization
|
It will be performed through a body composition monitor, evaluating weight, body Fat percentage, Muscle Mass, Basal Metabolic Rate, Bone Mass and Total Body Water Percentage.
|
Daily, as soon as medically appropriated, during the hospitalization
|
|
Change in Forced Expiratory Volume in the First Second
Time Frame: Daily, as soon as medically appropriated, during the hospitalization
|
It will be evaluated through espirometry
|
Daily, as soon as medically appropriated, during the hospitalization
|
|
Days in hospital
Time Frame: At the discharge
|
At the discharge
|
|
|
Change in Reported Dyspnea
Time Frame: Daily, as soon as medically appropriated, during the hospitalization
|
It will be evaluated through the Modified Medical Research Concil Questionnaire
|
Daily, as soon as medically appropriated, during the hospitalization
|
|
Change in Heart Rate Variability
Time Frame: first day of the protocol and at the day of discharge
|
It will be recorded through a cardiac monitor, and analized in the time and frequency domain, and non-linear analysis.
|
first day of the protocol and at the day of discharge
|
|
Quadriceps Isometric Force
Time Frame: first day of the protocol and at the day of discharge
|
It will be evaluated through a hand held dynamometer.
|
first day of the protocol and at the day of discharge
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Director: Valéria Amorim Pires Di Lorenzo, PhD, Universidade Federal de Sao Carlos
- Principal Investigator: Adriana Sanches Garcia de Araujo, Masters, Universidade Federal de Sao Carlos
- Principal Investigator: Juliano Ferreira Arcuri, Especialist, Universidade Federal de Sao Carlos
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002 Jul 1;166(1):111-7. doi: 10.1164/ajrccm.166.1.at1102. No abstract available. Erratum In: Am J Respir Crit Care Med. 2016 May 15;193(10):1185.
- Burtin C, Clerckx B, Robbeets C, Ferdinande P, Langer D, Troosters T, Hermans G, Decramer M, Gosselink R. Early exercise in critically ill patients enhances short-term functional recovery. Crit Care Med. 2009 Sep;37(9):2499-505. doi: 10.1097/CCM.0b013e3181a38937.
- Behnke M, Taube C, Kirsten D, Lehnigk B, Jorres RA, Magnussen H. Home-based exercise is capable of preserving hospital-based improvements in severe chronic obstructive pulmonary disease. Respir Med. 2000 Dec;94(12):1184-91. doi: 10.1053/rmed.2000.0949.
- Eaton T, Young P, Fergusson W, Moodie L, Zeng I, O'Kane F, Good N, Rhodes L, Poole P, Kolbe J. Does early pulmonary rehabilitation reduce acute health-care utilization in COPD patients admitted with an exacerbation? A randomized controlled study. Respirology. 2009 Mar;14(2):230-8. doi: 10.1111/j.1440-1843.2008.01418.x.
- Kovelis D, Segretti NO, Probst VS, Lareau SC, Brunetto AF, Pitta F. Validation of the Modified Pulmonary Functional Status and Dyspnea Questionnaire and the Medical Research Council scale for use in Brazilian patients with chronic obstructive pulmonary disease. J Bras Pneumol. 2008 Dec;34(12):1008-18. doi: 10.1590/s1806-37132008001200005. English, Portuguese.
- Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA, Pinto Plata V, Cabral HJ. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004 Mar 4;350(10):1005-12. doi: 10.1056/NEJMoa021322.
- Vogiatzis I, Terzis G, Nanas S, Stratakos G, Simoes DC, Georgiadou O, Zakynthinos S, Roussos C. Skeletal muscle adaptations to interval training in patients with advanced COPD. Chest. 2005 Dec;128(6):3838-45. doi: 10.1378/chest.128.6.3838.
- Vogiatzis I, Nanas S, Roussos C. Interval training as an alternative modality to continuous exercise in patients with COPD. Eur Respir J. 2002 Jul;20(1):12-9. doi: 10.1183/09031936.02.01152001.
- Anderson D, Macnee W. Targeted treatment in COPD: a multi-system approach for a multi-system disease. Int J Chron Obstruct Pulmon Dis. 2009;4:321-35. doi: 10.2147/copd.s2999. Epub 2009 Sep 1.
- Burge S, Wedzicha JA. COPD exacerbations: definitions and classifications. Eur Respir J Suppl. 2003 Jun;41:46s-53s. doi: 10.1183/09031936.03.00078002.
- Faganello MM, Tanni SE, Sanchez FF, Pelegrino NR, Lucheta PA, Godoy I. BODE index and GOLD staging as predictors of 1-year exacerbation risk in chronic obstructive pulmonary disease. Am J Med Sci. 2010 Jan;339(1):10-4. doi: 10.1097/MAJ.0b013e3181bb8111.
- Gerardi DA, Lovett L, Benoit-Connors ML, Reardon JZ, ZuWallack RL. Variables related to increased mortality following out-patient pulmonary rehabilitation. Eur Respir J. 1996 Mar;9(3):431-5. doi: 10.1183/09031936.96.09030431.
- Iucif N Jr, Rocha JS. [Study of inequalities in hospital mortality using the Charlson comorbidity index]. Rev Saude Publica. 2004 Dec;38(6):780-6. doi: 10.1590/s0034-89102004000600005. Epub 2004 Dec 10. Portuguese.
- MacNee W, Tuder RM. New paradigms in the pathogenesis of chronic obstructive pulmonary disease I. Proc Am Thorac Soc. 2009 Sep 15;6(6):527-31. doi: 10.1513/pats.200905-027DS.
- Mathers CD, Boerma T, Ma Fat D. Global and regional causes of death. Br Med Bull. 2009;92:7-32. doi: 10.1093/bmb/ldp028.
- Nasis IG, Vogiatzis I, Stratakos G, Athanasopoulos D, Koutsoukou A, Daskalakis A, Spetsioti S, Evangelodimou A, Roussos C, Zakynthinos S. Effects of interval-load versus constant-load training on the BODE index in COPD patients. Respir Med. 2009 Sep;103(9):1392-8. doi: 10.1016/j.rmed.2009.03.003. Epub 2009 Apr 5.
- Murphy N, Bell C, Costello RW. Extending a home from hospital care programme for COPD exacerbations to include pulmonary rehabilitation. Respir Med. 2005 Oct;99(10):1297-302. doi: 10.1016/j.rmed.2005.02.033. Epub 2005 Mar 31.
- Ong KC, Earnest A, Lu SJ. A multidimensional grading system (BODE index) as predictor of hospitalization for COPD. Chest. 2005 Dec;128(6):3810-6. doi: 10.1378/chest.128.6.3810.
- Oxford KL. Elbow positioning for maximum grip performance. J Hand Ther. 2000 Jan-Mar;13(1):33-6. doi: 10.1016/s0894-1130(00)80050-2.
- Pinto-Plata VM, Cote C, Cabral H, Taylor J, Celli BR. The 6-min walk distance: change over time and value as a predictor of survival in severe COPD. Eur Respir J. 2004 Jan;23(1):28-33. doi: 10.1183/09031936.03.00034603.
- Puhan M, Scharplatz M, Troosters T, Walters EH, Steurer J. Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2009 Jan 21;(1):CD005305. doi: 10.1002/14651858.CD005305.pub2.
- Seemungal TA, Hurst JR, Wedzicha JA. Exacerbation rate, health status and mortality in COPD--a review of potential interventions. Int J Chron Obstruct Pulmon Dis. 2009;4:203-23. doi: 10.2147/copd.s3385. Epub 2009 Jun 11.
- Urbano FL, Pascual RM. Contemporary issues in the care of patients with chronic obstructive pulmonary disease. J Manag Care Pharm. 2005 Jun;11(5 Suppl A):S2-13; quiz S14-6. doi: 10.18553/jmcp.2005.11.s5-a.1.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2011
Primary Completion (Anticipated)
August 1, 2012
Study Completion (Anticipated)
August 1, 2012
Study Registration Dates
First Submitted
February 11, 2011
First Submitted That Met QC Criteria
February 11, 2011
First Posted (Estimate)
February 14, 2011
Study Record Updates
Last Update Posted (Estimate)
March 21, 2011
Last Update Submitted That Met QC Criteria
March 18, 2011
Last Verified
February 1, 2011
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- DPOCexacaminhada
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Obstructive Pulmonary Disease
-
Spire, Inc.ResMedCompletedSevere Chronic Obstructive Pulmonary Disease | Moderate Chronic Obstructive Pulmonary DiseaseUnited States
-
University of LeicesterUniversity Hospitals, Leicester; University of StrathclydeRecruitingChronic Obstructive Pulmonary Disease (COPD) | Chronic Obstructive Lung Disease | Chronic Obstructive Airway DiseaseUnited Kingdom
-
National Taipei University of Nursing and Health...TerminatedChronic Pulmonary Disease | Chronic Obstructive Pulmonary Disease Exacerbation | Chronic Obstructive Pulmonary Disease With ExacerbationTaiwan
-
Karaganda Medical UniversityCompletedChronic Obstructive Pulmonary Disease | Chronic Obstructive Pulmonary Disease Moderate | Chronic Obstructive Pulmonary Disease SevereKazakhstan
-
Randall DebattistaUniversity of Malta, Faculty of Health SciencesNot yet recruitingChronic Obstructive Pulmonary Disease Moderate | Acute Exacerbation of COPD | Chronic Obstructive Pulmonary Disease Severe
-
Cukurova UniversityCompletedAnesthesia | Chronic Obstructive Pulmonary Disease Moderate | Lungcancer | Chronic Obstructive Pulmonary Disease Severe | Chronic Obstructive Pulmonary Disease MildTurkey
-
Taipei Medical UniversityUnknownChronic Obstructive Pulmonary Disease Severe | Chronic Obstructive Pulmonary Disease End StageTaiwan
-
Hopital FochAir Liquide SARecruitingChronic Obstructive Pulmonary Disease SevereFrance
-
Fundación para la Investigación del Hospital Clínico...Not yet recruitingCOPD, Chronic Obstructive Pulmonary DiseaseSpain
-
Canandaigua VA Medical CenterRecruitingChronic Obstructive Pulmonary Disease ModerateUnited States
Clinical Trials on Ground Walking Program
-
Marmara UniversityNot yet recruiting
-
Istanbul UniversityCompleted
-
Samsung Medical CenterCompletedAgingKorea, Republic of
-
Pacific Northwest University of Health SciencesTerminatedParkinson DiseaseUnited States
-
University GhentKU Leuven; Research Foundation FlandersRecruitingHealthy Aging | Cognitive Decline | Physical InactivityBelgium
-
East Tennessee State UniversityRecruitingPARKINSON DISEASE (Disorder)United States
-
University of Texas Southwestern Medical CenterTerminated
-
Texas Woman's UniversityTexas Physical Therapy AssociationCompletedTotal Knee ArthroplastyUnited States
-
Columbia UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National...CompletedPrimary Hyperparathyroidism | Bone Diseases, Metabolic | Osteoporosis, Postmenopausal | Bone Loss, PostmenopausalUnited States
-
VA Office of Research and DevelopmentRecruitingPeripheral Artery DiseaseUnited States